Characteristics of neutrophils and monocyets in patients with end stage kidney disease and those undergoing hemodialysis
Abstract
Chronic kidney disease is characterised by irreversible impairment of kidney function
due to compromise in glomerular filtration. Clinical presentation progresses from
asymptomatic initial stages to end stage kidney disease (ESKD) with complications.
Clinical management is mainly focussed on slowing the progression and associated
complications. However, in advanced stage of CKD, renal replacement therapy is
sought; the most common among them being hemodialysis. HD involves diffusive
transport of metabolic waste products across a semipermeable membrane into a
dialysate solution. The procedure employs long tubings and a dialyzer which acts as
artificial kidney into which blood is made to circulate extracorporeally and then
shunted back into the body through another set of tubings after dialysis. Immune
cells come into contact with these foreign materials at regular intervals and their
function is altered. There is also a state of hypercytokinemia due to their decreased
elimination creating an environment of chronic inflammation. One of the leading
causes of mortality in HD is infections. Neutrophils and monocytes are inflammatory
responders of the innate immune system playing a vital role in combating infections.
While the various cytokines involved in inflammation have been studied, there is a
paucity in knowledge on neutrophil phenotype and function and the changes that
take place at different stages of HD. Similarly conflicting results from monocyte
phenotype studies also needed further relook. With this background, we proceeded
to characterize the phenotype and function of neutrophils and monocytes in patients
at different stages of CKD and compared them to healthy controls.
To achieve this, we recruited four groups of individuals; those with stage 5 CKD, not
on dialysis (pre-dialysis/ pre-HD); those who are in their 6 to 12 months of HD (short
term HD); those who received more than 2 years of HD (long-term HD); age
matched apparently healthy controls (HCs). Peripheral venous blood samples were
drawn before the start of HD and immune cells were isolated to characterize their
phenotype and function using flow cytometry-based experiments.
Firstly, we compared the characteristics of circulating neutrophils and monocytes
obtained from subjects prior to dialysis (pre-HD) to healthy controls (HCs), followed
by comparisons within the CKD sub-groups. Our findings showed that there were
more immature neutrophils in the CKD group not on dialysis (pre-HD). The
neutrophils in the pre-HD group showed specific functional alterations, such as
lowered phagocytic ability. We also studied the low-density neutrophils (LDNs),
which are found commonly in chronic conditions and malignancies, and found that
the mean LDN percentage among the PBMCs are higher in the pre-HD group.
Together, this data suggests that CKD results in impaired neutrophil numbers,
phenotype and function when compared to HCs.
Between the CKD sub-groups, the group on long-term HD showed neutrophils with
the highest phagocytic ability, but had the lowest ability to produce reactive oxygen
species. We also studied the CD36 (scavenger molecule) expression which is shown
to be associated with atherosclerosis; it was higher in both the HD groups of CKD
when compared to pre dialysis group. We did not prospectively follow up the patients
from pre-HD stage to long-term HD. Hence, definitive conclusions cannot be made
on the progression of marker expression in CKD.
The study gathered other clinical and demographic details generating
multiparametric data. While large-scale studies can reveal the distribution of
variables, correlations, and trends using dimensionality reduction tools, this pilot
study serves as a foundational step. It can inform power analysis for designing future
large, multicentric cohort studies. The data generated from such studies can yield
meaningful conclusions that help in modulating therapeutics for improved clinical
outcomes.